Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,398 GBX | +0.47% |
|
-0.55% | +16.96% |
Jun. 20 | AstraZeneca Says Truqap With Faslodex Combination Approved in EU for Breast Cancer | MT |
Jun. 20 | AstraZeneca's Truqap gets OK from EU for breast cancer form | AN |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.96% | 243B | |
+51.99% | 803B | |
-5.72% | 351B | |
+18.94% | 324B | |
+11.07% | 303B | |
+2.25% | 228B | |
+11.15% | 217B | |
+7.59% | 164B | |
-3.65% | 155B | |
-1.84% | 117B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- ASTRAZENECA : UBS drops its Sell rating